BOSTON – May 13, 2026 – Global law firm Greenberg Traurig, LLP has been recognized with the “Best in Patent Portfolio Management Award” by Life Sciences Patent Network (LSPN), underscoring the firm’s excellence and leadership in life sciences intellectual property (IP). The honor marks the firm’s second consecutive year of recognition from LSPN, following Greenberg Traurig’s selection as “Life Sciences Patent Strategy Firm of the Year” in 2025.
The LSPN judges commented: “Greenberg Traurig demonstrates outstanding strength in aligning IP strategy with client business objectives, underpinned by impressive and well-established experience in the medical devices sector. The submission articulates clear and compelling expertise across the life sciences landscape, showcasing a firm that deeply understands how to connect IP strategy to the commercial goals of its clients. Overall, the firm has considerable capability and depth across the field.”
In a joint statement, Co-Chairs of Greenberg Traurig’s Global Life Sciences & Medical Technology Group David J. Dykeman and Wayne H. Elowe said: “This recognition reflects our team’s focus on building patent portfolios that are designed to protect innovation, drive enterprise value, enable strategic transactions, and support long-term growth for our clients. Greenberg Traurig is honored that LSPN recognized not only the scale of our practice, but the real-world impact of the work we do alongside leading life sciences companies worldwide.”
As previously announced, Greenberg Traurig was also a finalist for “Life Sciences Prosecution Firm of the Year” and “Medical Device IP Firm of the Year.”
Organized by Life Sciences Intellectual Property Review, the LSPN Awards USA 2026 recognize outstanding achievements in pharmaceutical and biotech patent protection. These awards celebrate the organizations that are pushing boundaries, delivering exceptional results, and shaping the future of life sciences IP. Winners were announced at an awards ceremony April 30 at the Hyatt Regency.